Supplement evidence

097 / 575Cardiometabolic

Myo-inositol

View my plan →

The short answer

Has evidence for selected PCOS, fertility, and insulin-related outcomes; live-birth and long-term outcomes are less certain.

Evidence and scope: Conditional or population-specific
This status does not grade the ingredient for every goal, outcome, or person.
Important limitation: Benefit depends on the population, formulation, baseline status, and objective; results should not be generalized.
Before deciding: Key concern: Glucose-lowering medicines, bipolar disorder, fertility treatment, pregnancy, and kidney disease require review.

01 / PRACTICAL GUIDE

Dose, absorption, and combinations

These are indication-specific reference or studied ranges—not a personalized prescription. Start with the objective, then check the form, label, medicines, and health conditions.

Reference range by objective

Glucose-related research2 g twice daily is common in PCOS trials

Reference or studied range—not a personalized prescription. The product label or a clinician may specify a different dose.

Dose source ↗

Mood symptomsHigher psychiatric-study doses require clinician oversight

Reference or studied range—not a personalized prescription. The product label or a clinician may specify a different dose.

Dose source ↗

More is not automatically better. A clinician or product label may specify a different amount.

Absorption / solubilityWater-soluble

Water-soluble or readily water-dispersible. This does not mean excess is always harmless.

How it is commonly taken

Divide with meals for tolerance.

Do not combine casually

Glucose-lowering medicines, bipolar disorder, fertility treatment, pregnancy, and kidney disease require review.

Dose and use source ↗

Dose and use links lead to primary or official source material. Search links are discovery tools, not proof that every returned paper applies.

02 / EVIDENCE

What the research says

We keep supportive, mixed, negative, safety, and contextual findings together. The headline never replaces the underlying papers.

1research papers in this ledger

30unique primary studies represented

2,230unique participants represented

These are audited counts for this JIVANA collection, not search-result totals. Participants are counted once when multiple papers use the same cohort; review papers are not added again to participant totals.

Open the research timelineResearch timeline

Entries are ordered by publication year. A study period appears only when the source reports it.

2024

Mixed or qualifiedPMID 38163998

Inositol for polycystic ovary syndrome: evidence review for the international guideline

Some metabolic measures may improve, but effects on many outcomes were absent or uncertain. The guideline evidence review judged support for inositol in PCOS limited and inconclusive and called for shared decision-making rather than treating it as equivalent to established care.

Published: 2024n=2,230 participants30 primary studies represented

Study design and methods

Design: Systematic review and meta-analysis of 30 trials; 19 were pooled
Population: 2,230 women with polycystic ovary syndrome
Intervention: Myo-inositol, D-chiro-inositol, or combinations alone or with other therapies
Outcome: Hormonal, metabolic, lipid, psychological, body-size, reproductive, and adverse outcomes

Open research record ↗

Unscreened discovery appendix—not evidence56 candidate publicationsSearch run: Aug 21, 2026

Complete for the displayed PubMed query at the search timestamp—not for all databases or every possible synonym. Candidates can be irrelevant, duplicate the same study, or report negative findings. They are never summed as evidence or participants until screened.

03 / SOURCES

Start with the source material

Official evidence overviewPubMed bounded human-evidence search Live PubMed discovery searchNational Library of Medicine

The live search is for discovery only. Search-result counts change and are not included in the audited totals above.

Recent PubMed discovery recordsDirect links to the first 12 records returned by the reproducible search. These are discovery candidates—not reviewed summaries or a count of supportive findings.

04 / EXPERT CONTEXT

Expert context—not evidence

Expert positions are dated context—not scientific evidence. They never raise the evidence status or become consensus by repetition.

No direct, source-verified endorsement is currently recorded. Research authorship or discussion alone is not treated as endorsement.